《睡眠專業人士雜誌》
星期四, 七月 23, 2026
On 星期三 morning, CND Life Sciences presented exciting new data at SLEEP 2026 from the NIH-sponsored Syn-Sleep Study, indicating that its Syn-One Test detected phosphorylated alpha-synuclein (P-SYN) in 75% of patients with idiopathic REM sleep behavior disorder (RBD). SleepWorld had a chance to sit down with CND Chief Medical Officer and […]
Inspire Medical Systems, Inc. 參加了於 6 月 14 日至 17 日在馬里蘭州巴爾的摩舉行的 SLEEP 2026——即「專業睡眠學會聯合會」（APSS）第 40 屆年會。SLEEP 是睡眠醫學與研究領域的首要全球論壇，由美國睡眠醫學學會（AASM）與睡眠研究 […] 共同主辦。
New data presented by Takeda at SLEEP 2026 this week continues to build the case for oveporexton (TAK-861) as a potential disease-modifying treatment for narcolepsy type 1 (NT1). Oveporexton is designed to address the root cause of the disease, targeting the underlying orexin deficiency responsible for NT1. Results from two pivotal […]
Nyxoah announced the pricing of an underwritten public offering in the United States, which includes shares sold in a private offering to certain qualified or institutional investors outside the United States, including within the European Union, of 55,232,558 of its ordinary shares at an offering price of $1.72 (EUR 1.48) […]
Huxley Medical, a commercial-stage medical technology company expanding access to sleep apnea testing across health systems, cardiology, and primary care, today introduced two additions to its SANSA® platform: SANSA GO™, a point-of-care enrollment model that enables clinics to dispense SANSA at patient visits, and hypoxic burden, an additional measure of […]
Wesper unveiled its multi-tier sleep diagnostic ecosystem at SLEEP 2026, the annual meeting of the Associated Professional Sleep Societies. The ecosystem brings two purpose-built diagnostic pathways, Wesper Lab and Wesper Lite, onto one platform, one patient record, and one interpretation pipeline, so physicians can match the right test to the right […]
Alkermes plc announced plans to present new data from its industry-leading portfolio of sleep medicine research at SLEEP 2026, the 40th annual meeting of the Associated Professional Sleep Societies (APSS), taking place 六月 14-17, 2026 in Baltimore, MD. The company will present 26 abstracts, including posters featuring LUMRYZ® (sodium oxybate) extended-release oral […]
Jazz Pharmaceuticals announced that the company will present 21 abstracts, including 11 late-breaking abstracts, at SLEEP 2026, the 40th annual meeting of the Associated Professional Sleep Societies (APSS), taking place 六月 14-17, 2026, in Baltimore. The robust breadth of data reflects Jazz’s continued focus on advancing treatment for rare and difficult-to-treat sleep […]
Vitacore 宣布，其全球首款完全客製化的醫療級矽膠 CPAP 面罩 FormFit™ 已獲得加拿大衛生部頒發的醫療器材許可證（MDL）。隨著監管批准的取得，Vitacore 將正式在加拿大全國範圍內推出 FormFit™，消費者可透過 vitacore.com/formfit 直接購買，亦可透過全國各地參與合作的睡眠診所及醫療服務提供者取得。這項專利 […]
評估採用下頜前移裝置治療輕度至中度阻塞性睡眠呼吸中止症之虛擬照護模式的療效 作者：史蒂文·阿爾瓦拉多、彼得·巴拉基（牙科博士）、愛德華·金、丹尼爾·莫拉扎德、朱莉安娜·岡薩雷斯，以及馬丁·L·霍普（醫學博士、哲學博士） 這是一種常見的睡眠障礙，據估計影響了[…]約5,400萬人 […]
